ARS Pharmaceuticals SPRY
NASDAQ SPRY
$4.40 +0.27 (+6.54%)
At close: Sep 29, 2026 · 4:00 PM EDT

ARS Pharmaceuticals (SPRY) Total Current Liabilities (2020 - 2026)

Updated

ARS Pharmaceuticals (SPRY) recorded Total Current Liabilities of $60.86 million in Q2 2026, up 33.5% from $45.6 million a year earlier and up 22.7% from the prior quarter.

Analysis

ARS Pharmaceuticals (SPRY) Total Current Liabilities (2020 - 2026) Analysis & Trends

At the end of FY2025, ARS Pharmaceuticals reported Total Current Liabilities of $39.15 million, up 67.0% from FY2024.

  • Annual Total Current Liabilities has a five-year compound annual growth rate of 32.5% (FY2020 to FY2025).
  • Across earlier years, Total Current Liabilities came in at $23.44 million in FY2024 (+880.3%), $2.39 million in FY2023 (-56.1%), $5.44 million in FY2022 (-33.5%) and $8.19 million in FY2021 (-14.7%).
  • The Q2 2026 figure is the highest quarterly Total Current Liabilities in data going back to Q4 2020.
  • On a year-over-year basis, Total Current Liabilities has increased for eight consecutive quarters, with growth averaging 317.1% over the last eight quarters.
  • Peak year-over-year performance for Total Current Liabilities in the last five years was growth of 880.3% in Q4 2024, against a decline of 74.0% in Q3 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $49.61 million (Q1 2026), $39.15 million (Q4 2025) and $50.88 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 ARS Pharmaceuticals 410.68 Mn 266.88 Mn 20.81 Mn 60.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 60.86 Mn
Mar 31, 2026 49.61 Mn
Dec 31, 2025 39.15 Mn
Sep 30, 2025 50.88 Mn
Jun 30, 2025 45.60 Mn
Mar 31, 2025 27.62 Mn
Dec 31, 2024 23.44 Mn
Sep 30, 2024 16.62 Mn
Jun 30, 2024 6.73 Mn
Mar 31, 2024 3.72 Mn
Dec 31, 2023 2.39 Mn
Sep 30, 2023 11.18 Mn
Jun 30, 2023 10.05 Mn
Mar 31, 2023 9.84 Mn
Dec 31, 2022 5.44 Mn
Sep 30, 2022 3.99 Mn
Jun 30, 2022 11.14 Mn
Mar 31, 2022 14.81 Mn
Dec 31, 2021 8.19 Mn
Sep 30, 2021 15.35 Mn
API Access

ARS Pharmaceuticals Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=SPRY&period=max&api_key=YOUR_API_KEY